Superdiluted atropine at 0.01% reduces progression in children and adolescents. A 5 year study of safety and effectiveness
Diaz-Llopis, M., Pinazo-Durán, M.D.Volume:
93
Language:
english
Journal:
Archivos de la Sociedad Española de Oftalmología (English Edition)
DOI:
10.1016/j.oftale.2018.02.006
Date:
April, 2018
File:
PDF, 477 KB
english, 2018